Stereotaxis (STXS) Return on Capital Employed (2011 - 2026)
Stereotaxis' (STXS) quarterly Return on Capital Employed came in at 73.75% in Q1 2026, up 4416.0% year-on-year from 1.63% in Q1 2025, and up 11.42% on a QoQ basis from 83.26% in Q4 2025.
Stereotaxis (STXS) Return on Capital Employed (2011 - 2026) Analysis & Trends
Stereotaxis (STXS) has 16 years of Return on Capital Employed data on file, last reported at 73.75% in Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 4416.0% year-over-year to 73.75% in Q1 2026; TTM through Mar 2026 was 73.75%, a 4416.0% increase from a year earlier, with the FY2025 full-year figure at 81.51%, up 2740.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 73.75%, up from 83.26% in the prior quarter.
- Over the last five years, Return on Capital Employed for STXS reached as high as 32.38% in Q1 2022 and fell as low as 117.9% in Q1 2025.
- Historically, Return on Capital Employed has averaged 73.18% across 5 years, with a median of 73.75% in 2026.
- Across the five-year window, Return on Capital Employed tumbled 4256 bps in 2025 and surged 4416 bps in 2026, its largest moves.
- Year by year, Return on Capital Employed stood at 46.41% in 2022, then plunged by 57 bps to 72.87% in 2023, then declined by 25 bps to 90.86% in 2024, then advanced by 8 bps to 83.26% in 2025, then climbed by 11 bps to 73.75% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 73.75% in Q1 2026, 83.26% in Q4 2025, and 104.69% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 28.56% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 18.58% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 5.02% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 25.95% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 19.71% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.68% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 19.44% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 12.74% |
| 10 | Stereotaxis | 136.49 Mn | 121.87 Mn | 3.79 Mn | -73.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -73.75% |
| Dec 31, 2025 | -83.26% |
| Sep 30, 2025 | -104.69% |
| Jun 30, 2025 | -105.23% |
| Mar 31, 2025 | -117.90% |
| Dec 31, 2024 | -90.86% |
| Sep 30, 2024 | -98.52% |
| Jun 30, 2024 | -85.20% |
| Mar 31, 2024 | -75.34% |
| Dec 31, 2023 | -72.87% |
| Sep 30, 2023 | -62.87% |
| Jun 30, 2023 | -58.08% |
| Mar 31, 2023 | -53.73% |
| Dec 31, 2022 | -46.41% |
| Sep 30, 2022 | -43.28% |
| Jun 30, 2022 | -39.72% |
| Mar 31, 2022 | -32.38% |
| Dec 31, 2021 | -26.74% |
| Sep 30, 2021 | -23.40% |
| Jun 30, 2021 | -17.16% |